Scalper1 News
Biotechs Anacor Pharmaceuticals (ANAC) and Regeneron Pharmaceuticals (REGN) were both trading up Monday on the potential of their drug candidates for atopic dermatitis (AD). Anacor stock soared 55% to a new high above 131 on the strength of late-stage trial results for its ointment Crisaborole. The company said half the patients with mild to moderate AD — a recurring skin inflammation of unknown origin — were clear or almost clear of the rash Scalper1 News
Scalper1 News